Skip to main content
. 2022 May 15;12(5):2293–2309.

Table 1.

Mechanism of action and GI50 values of agents used

Cmpd Mechanism of Action U2OS GI50 (μM) Ref

Mean SD
V158411 Chk1 Inhibitor 0.82 0.1 [11]
VX-970 ATR Inhibitor 3.5 0.77 [50]
AZD1775 Wee1 Inhibitor 0.27 0.036 [51]
Gemcitabine Chain terminator & RNR inhibitor 0.012 0.001
Camptothecin Topo I inhibitor 0.25 0.003
Etoposide Topo II inhibitor 4.2 0.32
LY2603618 Chk1 inhibitor 0.67 0.05 [52]
MK8776 Chk1 inhibitor 0.82 0.05 [53]
PF-477736 Chk1 inhibitor 0.71 0.06 [54]
Cisplatin DNA alkylator 7.5 0.77
Hydroxyurea RNR inhibitor 2800 1100
KU-60019 ATM inhibitor 24 9.2 [55]
NU7746 DNA-PKcs inhibitor 8.6 0.48 [56]